Haemophilia

Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature
pp. 685-696(12)
Authors: ASATIANI, E.; KESSLER, C. M.

Safety and efficacy of a plasma-derived monoclonal purified factor VIII concentrate during 10 years of follow-up
pp. 697-700(4)
Authors: MAUSER-BUNSCHOTEN, E. P.; POSTHOUWER, D.; FISCHER, K.; VAN DEN BERG, H. M.

Galectin 3-binding protein is a potential contaminant of recombinantly produced factor IX
pp. 701-706(6)
Authors: BLOSTEIN, M.; CUERQUIS, J.; GALIPEAU, J.

Inhibitor development and successful immune tolerance in an HIV-infected patient with haemophilia A and after immune reconstitution with HAART
pp. 707-711(5)
Authors: KRUSE-JARRES, R.; HADI, C. M.; LEISSINGER, C. A.

Implementation of a hepatitis A prevention policy in haemophiliacs: results from the French cohort
pp. 712-721(10)
Authors: CHAMBOST, H.; DONCARLI, A.; BERTRAND, M.-A.; BRIQUEL, M.-E.; GAY, V.; PINCEMAILLE, O.; TROSSAERT, M.; CALVEZ, T.

Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patients
pp. 722-729(8)
Authors: MAOR, Y.; CALÈS, P.; BASHARI, D.; KENET, G.; LUBETSKY, A.; LUBOSHITZ, J.; SCHAPIRO, J. M.; PÉNARANDA, G.; BAR-MEIR, S.; MARTINOWITZ, U.; HALFON, P.

Experience with epidural anaesthesia in pregnant women with von Willebrand disease
pp. 730-733(4)
Authors: VARUGHESE, J.; COHEN, A. J.

Correlation of thromboelastographic patterns with clinical presentation and rationale for use of antifibrinolytics in severe haemophilia patients
pp. 734-739(6)
Authors: GHOSH, K.; SHETTY, S.; KULKARNI, B.

Analysing two dinucleotide repeats of FVIII gene in Iranian population
pp. 740-744(5)
Authors: RABBANI, B.; REZAEIAN, A.; KHANAHMAD, H.; BAGHERI, R.; KAMALI, E.; ZEINALI, S.

The economics of haemophilia prophylaxis: governmental and insurer perspectives. PROCEEDINGS OF THE SECOND INTERNATIONAL PROPHYLAXIS STUDY GROUP (IPSG) SYMPOSIUM
pp. 745-749(5)
Authors: FELDMAN, B. M.; ALEDORT, L.; BULLINGER, M.; DELANEY, F. M.; DORIA, A. S.; FUNK, S.; GIANGRANDE, P.; LUNDIN, B.; MANCO-JOHNSON, M.; MINERS, A.; SCRIBA, P. C.; SRIVASTAVA, A.; SCHRAMM, W.; BLANCHETTE, V. S.

Coagulation deficiencies: a look to the future
pp. 750-757(8)
Authors: LEE, C. A.; ALEDORT, L. M.

Venous thrombosis in Glanzmann's thrombasthenia
pp. 758-759(2)
Authors: PHILLIPS, R.; RICHARDS, M.

Treatment in a haemophiliac A patient with paroxysmal atrial fibrillation and ischemic heart disease
pp. 760-762(3)
Authors: CID, A. R.; ZORIO, E.; HAYA, S.; ZÚÑIGA, P.; RUEDA, J.; CASAÑA, P.; CABRERA, N.; ARNAU, M. A.; AZNAR, J. A.

Management of an acute coronary syndrome in a patient with severe haemophilia A
pp. 763-765(3)
Authors: FERRARIO, C.; RENDERS, F.; CAIROLI, A.; VUFFRAY, A.; SPERTINI, O.; ANGELILLO-SCHERRER, A.

Factor VIII inhibitor associated with nephrotic syndrome
pp. 766-766(1)
Authors: CHANG, H.; CHEN, Y.M.; DUNN, P.

Successful liver transplant in an HCV-infected haemophiliac patient with fulminant hepatic failure
pp. 767-769(3)
Authors: MANDALÀ, L.; PIETROSI, G.; GRUTTADAURIA, S.; VIZZINI, G.; SPAMPINATO, M.; SPADA, M.; BURGIO, G.; ARCADIPANE, A.; IDA MINERVINI, M.; PAGNUCCO, G.; PALAZZO, U.; GRIDELLI, B.

Haemoperitoneum in a female patient with haemophilia A caused by a ruptured ovarian follicle
pp. 770-771(2)
Authors: MARTIN-SALCES, M.; JIMENEZ-YUSTE, V.; ALVAREZ, M. T.; QUINTANA, M.; HERNANDEZ-NAVARRO, F.

Prenatal diagnosis of haemophilia A by using intron 1 inversion detection
pp. 772-774(3)
Authors: SALVIATO, R.; BELVINI, D.; ZANOTTO, D.; DI GAETANO, R.; RADOSSI, P.; SARTORI, R.; TASSINARI, C.; TAGARIELLO, G.